Multiethnic prevalence of the APOL1 G1 and G2 variants among the Israeli dialysis population
Authors:
Open Access
- 6 December 2024
- journal article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 18 (2) , sfae397
Abstract
Background and hypothesis: The two apolipoprotein L1 (APOL1) variants, G1 and G2, are common in populations of sub-Saharan African ancestry. Individuals with two of these alleles (G1 or G2) have an increased risk for a spectrum of non-diabetic chronic kidney diseases. However, these variants are typically not observed outside of populations that self-identify as current continental Africans or having clear recent African ancestry such as, most notably, African Americans, and other large population groups in the Americas and several European countries. We hypothesized that the diverse ethnic groups within the Israeli population may exhibit varying levels of recent African ancestry. Therefore, it is plausible that APOL1 risk alleles might be present even in individuals who do not self-identify as being of sub-Saharan African descent. Methods: We non-selectively screened people with kidney failure across Israel for APOL1 risk variants using restriction fragment length polymorphism. Results: We recruited 1744 individuals from 38 dialysis units in Israel. We identified eight patients of Moroccan Jewish, Bedouin, or Muslim Arab ancestry, who carry at least one G1 or G2 allele. None of the eight patients carried the protective APOL1 p.N264K variant. Furthermore, despite all Bedouin individuals being G2 heterozygous, the G2 minor allele frequency was significantly enriched in kidney failure cases compared to ethnically matched controls (P = .006). Conclusions: These findings show that APOL1 G1 and G2 allelic variants are present in populations previously not appreciated to possess recent sub-Saharan ancestry and suggest that a single G2 risk variant may confer increased risk for chronic kidney disease in certain population contexts.Keywords
Funding Information
- European Research Council (#101040267-GeneCKD)
- Israel Science Foundation (3757/20)
This publication has 45 references indexed in Scilit:
- The population genetics of chronic kidney disease: insights from the MYH9–APOL1 locusNature Reviews Nephrology, 2011
- The History of African Gene Flow into Southern Europeans, Levantines, and JewsPLOS Genetics, 2011
- Association of Trypanolytic ApoL1 Variants with Kidney Disease in African AmericansScience, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- The genome-wide structure of the Jewish peopleNature, 2010
- African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic AmericansHuman Molecular Genetics, 2010
- The Druze: A Population Genetic Refugium of the Near EastPLOS ONE, 2008
- Apolipoprotein L-I is the trypanosome lytic factor of human serumNature, 2003
- Out of Africa and back again: nested cladistic analysis of human Y chromosome variationMolecular Biology and Evolution, 1998